BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Accenture
Dow
Cantor Fitzgerald
Fuji
Citi
Merck
US Department of Justice
McKesson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019498

« Back to Dashboard

NDA 019498 describes PARATHAR, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the PARATHAR profile page.

The generic ingredient in PARATHAR is teriparatide acetate. There are three drug master file entries for this compound. Additional details are available on the teriparatide acetate profile page.
Summary for 019498
Tradename:PARATHAR
Applicant:Sanofi Aventis Us
Ingredient:teriparatide acetate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength200 UNITS/VIAL
Approval Date:Dec 23, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Chubb
Novartis
Colorcon
Julphar
Moodys
Federal Trade Commission
Merck
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot